RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) today announced that an affiliate of, or a fund sponsored by, Kohlberg Kravis Roberts & Co., intends to offer for sale in an underwritten secondary offering 6,500,000 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholder will receive all of the proceeds from this offering. No shares are being sold by the Company. The last reported sale price of the Company’s common stock on August 6, 2018 was $104.33 per share. The offering is expected to close on August 9, 2018, subject to customary closing conditions.

Morgan Stanley and Goldman Sachs & Co. LLC will act as the underwriters for the offering.